CYP2A13 antibody (C-Term)
Quick Overview for CYP2A13 antibody (C-Term) (ABIN630443)
Target
See all CYP2A13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- CYP2 A13 antibody was raised against the C terminal of CYP2 13
-
Purification
- Purified
-
Immunogen
- CYP2 A13 antibody was raised using the C terminal of CYP2 13 corresponding to a region with amino acids DPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELF
-
-
-
-
Application Notes
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CYP2A13 Blocking Peptide, (ABIN937498), is also available for use as a blocking control in assays to test for specificity of this CYP2A13 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CYP0 13 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
-
Alternative Name
- CYP2A13
-
Background
- CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.
-
Molecular Weight
- 54 kDa (MW of target protein)
Target
-